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Objectives: to compare the clinical course and outcome of mesenteric vein thrombosis due to known causes and mesenteric 
vein thrombosis of unknown aetiology. 
Design: a retrospective study. 
Setting: two major general hospitals in Kuwait. 
Subjects: 12 patients who had mesenteric vein thrombosis due to known causes and seven patients who had mesenteric vein 
thrombosis of unknown aetiology were treated over eight years. 
Chief outcome measures: severity of clinical findings and outcome. 
Results: There was no statistical difference between the two groups in the clinical presentation or in outcome. 
Conclusion: 36% of mesenteric vein thrombosis occurred without an obvious cause although the disease appeared to be the 
same. More work on the aetioIogy of this condition is required. 
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Introduction 
Mesenteric vein thrombosis (MVT) was first described 
as a distinct clinical entity in 19351"2 and is an 
uncommon cause of bowel infarction. B" 4 Sepsis, liver 
cirrhosis, portal stasis, trauma, pregnancy or contra- 
ceptive pills may cause it. s-7 If MVT cannot be 
attributed to any known cause then it is called 
spontaneous or primary mesenteric vein thrombo- 
sis. 5'8 Since primary mesenteric vein thrombosis 
(PMVT) is defined in a negative manner, this might be 
due to failure of current diagnostic methods. The aim 
of this retrospective study was to test the theory that 
PMVT is a separate ntity by analysing the difference 
in the mode of clinical presentation and outcome of 
both PMVT and secondary mesenteric vein thrombo- 
sis (SMVT). 
disease were designated as SMVT; four had portal 
hypertension due to bilharzial liver fibrosis, four had 
heart failure, three had hypercoagulable states (two 
due to antithrombin III factor deficiency and one due 
to polycythemia) nd one female was pregnant. The 
remaining seven patients had no obvious predispos- 
ing factor to explain the disease and were designated 
as PMVT. Both groups were compared regarding the 
clinical course and histopathological findings. 
Statistical analysis was performed using Fisher's 
exact est for categorical data and the Wilcoxon Mann- 
Whitney test for ordinal data. 9Both tests are suitable 
for small independent samples. Due to the small 
numbers of this rare disease the ordinal data was 
presented with median (range) values. A confidence 
level of less than 5% was considered significant. 
Patients and Methods 
A review of the records of 19 patients who had 
histopathologically proven MVT and were treated 
between January 1983 and April 1990 at Adan and 
Mubarak A1-Kabeer Hospital was performed. Twelve 
patients who had predisposing factors to explain the 
Please address all correspondence to: Fikri Abu-Zidan, Dept. of 
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Results 
Two females were affected with PMVT while one had 
SMVT. The median age was 40 yrs for PMVT (range: 
20-80 yrs) and 48.5 yrs for SMVT (range: 24-75 yrs). 
The symptoms of the patients on presentation are 
shown in Table 1. Pain was usually colicky in nature at 
the onset becoming constant in those who were not 
subjected to an early surgical intervention. There was 
no difference between the two groups concerning the 
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Table 1. Symptoms 
SMVT PMVT 
No. of patients 12 7 
Abdominal pain 12 7 
Nausea 7 3 
Vomiting 7 4 
Bleeding per rectum 6 1 
Constipation 3 5 
Haematemesis 5 3 
Fever 8 4 
character of the pain nor the duration of symptoms 
[median (range), SMVT vs.  PMVT: 3.5 (0.5-15) days vs.  
4 (2-20) days]. Recurrent abdominal pain was present 
in 5/12 of SMVT and 2/7 of PMVT. A disproportion 
between the intensity of abdominal pain and abdomi- 
nal findings was noticed in 7/12 in SMVT and 4/7 in 
PMVT. The clinical findings of the patients on presen- 
Table 2. Clinical findings 
SMVT PMVT 
No. of patients 12 7 
Tenderness 11 7 
Guarding 5 3 
Abdominal distension 10 6 
Sluggish bowel sounds 7 1 
Shock 5 1 
Ascites 4 0 
Blood on PR examination 5 0 
Abdominal mass 3 2 
tation are shown in Table 2. The white cell counts and 
haematocrit values were similar in both groups 
[median (range), SMVT vs .  PMVT, 15.5 (8.4-37) × 
109/1 and 50 (30-62.6) % vs.  18.5 (9-34.9) × 109/1 and 
44.8 (30-51) %] respectively. The diagnostic work up 
was similar in both groups as shown by Table 3. A 
correct preoperative diagnosis was achieved in only 
two patients with SMVT and one with PMVT. The 
median delay before the decision to perform surgery 
was 1.25 days in SMVT (range: 3 h-5 days) and 4 days 
in PMVT (range: 3 h-10 days). 
At laparotomy serosanguineous fluid was found 
in 17 patients and the amount ranged between 
500-2000 ml. In all patients the pulsations of the main 
branches of superior mesenteric artery were felt 
operatively although the bowel was gangrenous. The 
vessels at the mesenteric border of the gangrenous 
bowel were dissected and transected to be sure that 
the thrombosis was only in the veins. Eighteen 
patients had resection of the gangrenous bowel with a 
wide margin and primary reanastomosis. A 70-year- 
old patient with heart failure and SMVT who had 
complete gangrene of the small bowel was left without 
resection. One patient with PMVT had a successful 
portal vein thrombectomy. The median length of the 
excised bowel was 130 cm in SMVT (range: 60-370) 
and 70 cm in PMVT (range: 50-370 cm). A second-look 
operation was carried out in 3/12 patients with SMVT 
and in 4/7 with PMVT. All SMVT patients needed 
further esection on second look operation and two of 
them died while only 1/4 with PMVT needed further 
resection and he also died. 
Anti-coagulant therapy was administered in 4/6 
surviving patients with SMVT and in 3/6 surviving 
with PMVT. All patients who received anticoagulant 
therapy survived. The mortality was 6/12 in SMVT 
and 1/7 in PMVT. None of the differences in the 
clinical findings, laboratory results, operative findings 
or mortality reached statistical significance between 
SMVT and PMVT, although the trend to better 
survival in PMVT is of interest. 
The histopathological findings of the infarcted 
intestine was similar in both groups with foci of 
necrosis and ulceration limited to the mucosa. 
Oedema nd congestion i volved the whole thickness 
of the wall. The patients with bilharziasis had bilhar- 
zial granulomas adjacent o the blood vessels. Two 
specimens displayed bilharzial ovae within the throm- 
bus. All patients had mesenteric vein thrombosis 
while the peripheral arteries were patent. 
Discussion 
It is surprising that our understanding of PMVT has 
not progressed since the beginning of this century. 
2 Warren reviewed all reported cases of MVT in the 
period 1919-1930. PMVT constituted 30% (54/177) of 
all cases and 18 SMVT were due to appendicitis. With 
the development of antibiotics and aseptic surgical 
techniques intraabdominal sepsis as a cause of SMVT 
has declined and in our study there was no case due to 
sepsis. Excluding the cases of appendicitis n Warren's 
review, PMVT constituted 34% (54/159) of all mesen- 
teric vein thrombosis, a similar proportion to our 
study. The relationship between contraceptive pills 
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Table 3. Investigations 
Diagnostic method SMVT PMVT 
Plain abdomen X-ray 7/11: abnormal 5/6: 
5: distended loops 4: 
1: fluid levels 1: 
1: elevated ome of diaphragm 
Abdominal ultrasound 3/3: intraperitoneal fluid 
Upper GI endoscopy 2/3: 
1/3: 
Angiography 1: 
Peritoneal tap 1: 
abnormal 
distended loops 
air under diaphragm 
2/3: normal 
1/3: coilled intestinal loops in the flank 
gastritis 1/1: gastritis 
negative 
normal 1: normal 
bloody 2/2: bloody 
and pregnancy with SMVT has been reported. 7 One of 
our female patients developed MVT while she was 
pregnant. We could not find the cause of MVT in two 
females and they were considered to have PMVT. 
Females constituted 2/7 (30%) of PMVT in our study 
similar to those reported by Mathews 7/22 (32%). 8
PMVT is a rare disease; 22 cases were collected 
over 24 years in four major hospitals in U.S.)t. s Our 
seven patients were seen in two major hospitals over 8 
years. The rarity of the disease adds to the difficulty of 
understanding it. Preoperative diagnosis of MVT is 
reached in less than 20% of cases. 8The most important 
clinical finding is the disproportion between the 
abdominal pain and the abdominal findingsJ ° A 
history of recurrent abdominal pain was noticed in 
7/19 of our patients. This may indicate minor throm- 
bosis without infarction as it has been proven experi- 
mentally that venous collaterals may be able to 
overcome the mesenteric venous occlusion. 1 Major 
thrombotic events without infarction may result in a 
fibrotic gut segment. 8 Upper gastrointestinal bleeding 
in association with severe abdominal pain must not 
divert the attention away from the diagnosis of MVT. 
Endoscopy is usually reported as gastritis, possibly 
due to the stasis of the portal system. A deeper 
examination may even show necrotic duodenal 
mucosaJ 1Plain abdominal X-rays are non-specific but 
may show air under the diaphragm which indicates 
bowel perforation as occurred in one of our patients. 
Angiography is not always diagnostic as a 
detailed evaluation of the venous phase of the study 
and liberal use of vasodilator drug injection to 
enhance venous opacification preformed by an expert 
radiologist is essential to reach the diagnosis. 12CT 
scanning is accurate in detecting MVT which is seen as 
a high density vein wall surrounding a central filling 
defect. It may be associated with peritoneal f uid and 
thickening of the intestinal wall  pneumatosis and 
venous gas 13-15 but its use did not improve survivalJ 5
CT scan was not performed in any of our patients. 
The diagnosis of MVT is usually made at lapar- 
otomy. 4 Resection of a wide margin should be per- 
formed as the disease may recur. 3 This was also 
evident by our study. Although aplanned second look 
operation policy is advised by others 8' 16 our study 
cannot support this as 3/4 who had small bowel 
resection following second look operation died. Portal 
vein thrombectomy is sometimes useful 17 as was the 
case in one of our patients. Others believe that it is 
contraindicated as it removes only the central thrombi 
leaving the peripheral onesJ ° Postoperative anti- 
coagulation is vital. 3'5"8 All of our patients who 
received anticoagulant therapy survived although this 
may be biased. 
In conclusion, we could not prove our theory that 
PMVT is a separate clinical entity but about 40% of 
MVT remain without an obvious cause. This is a rare 
clinical situation and a high degree of clinical suspi- 
cion is essential for its diagnosis. More attention 
should be paid to the aetiology of this mysterious 
condition. 
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